Trial
NCT04414514
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Milton S. Hershey Medical Center
Collaborators
Incyte Corporation
Condition
Hidradenitis Suppurativa
Intervention
Ruxolitinib 1.5% Cream
Why stopped
The PI left the Institution and sponsor decided to close the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-28